Compare ATLO & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATLO | SGHT |
|---|---|---|
| Founded | 1903 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 186.3M | 193.2M |
| IPO Year | N/A | 2021 |
| Metric | ATLO | SGHT |
|---|---|---|
| Price | $23.09 | $8.49 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $6.66 |
| AVG Volume (30 Days) | 28.0K | ★ 225.5K |
| Earning Date | 01-23-2026 | 11-06-2025 |
| Dividend Yield | ★ 3.44% | N/A |
| EPS Growth | ★ 82.57 | N/A |
| EPS | ★ 1.80 | N/A |
| Revenue | $60,568,000.00 | ★ $76,052,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $12.47 |
| P/E Ratio | $12.96 | ★ N/A |
| Revenue Growth | ★ 18.60 | N/A |
| 52 Week Low | $15.75 | $2.03 |
| 52 Week High | $24.36 | $8.80 |
| Indicator | ATLO | SGHT |
|---|---|---|
| Relative Strength Index (RSI) | 60.56 | 62.99 |
| Support Level | $23.60 | $8.00 |
| Resistance Level | $24.12 | $8.73 |
| Average True Range (ATR) | 0.50 | 0.46 |
| MACD | 0.01 | -0.11 |
| Stochastic Oscillator | 50.20 | 69.26 |
Ames National Corporation is a United States-based bank holding company. It provides short-term and medium-term commercial, multi-family, and agricultural real estate loans, residential real estate loans, agricultural and business operating loans and lines of credit, equipment loans, vehicle loans, personal loans and lines of credit, home improvement loans and origination of mortgage loans for sale into the secondary market. The Banks also offer a variety of checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit and automated/video teller machine access. The banking segment generates revenues through personal, business, agricultural and commercial lending, and Others.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.